HomeBLUE • NASDAQ
add
bluebird bio Inc
Previous close
$8.46
Day range
$8.03 - $8.79
Year range
$5.80 - $38.40
Market cap
82.25M USD
Avg Volume
583.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 10.61M | -14.36% |
Operating expense | 62.94M | -36.60% |
Net income | -60.81M | 30.29% |
Net profit margin | -573.01 | 18.60% |
Earnings per share | -6.20 | 53.03% |
EBITDA | -48.76M | 44.96% |
Effective tax rate | 0.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 70.65M | -59.46% |
Total assets | 465.06M | -24.21% |
Total liabilities | 470.84M | 20.40% |
Total equity | -5.79M | — |
Shares outstanding | 9.72M | — |
Price to book | -14.10 | — |
Return on assets | -31.73% | — |
Return on capital | -39.19% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -60.81M | 30.29% |
Cash from operations | -68.93M | -37.72% |
Cash from investing | 466.00K | -99.25% |
Cash from financing | -6.10M | 48.42% |
Net change in cash | -74.57M | -38,339.49% |
Free cash flow | -48.44M | 22.76% |
About
bluebird bio, Inc., based in Somerville, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders.
The company's only - in the European Union - approved drug is betibeglogene autotemcel, which treats transfusion-dependent beta thalassemia, a rare genetic blood disorder, and has been approved for use by the European Medicines Agency. The company has been criticized for the $1.8 million cost of the drug, which is the second most expensive drug in the world.
The company is developing LentiGlobin gene therapy for the treatment of sickle cell disease and cerebral adrenoleukodystrophy. It is also developing T cell product candidates to treat acute myeloid leukemia, Merkel-cell carcinoma, diffuse large B-cell lymphoma, and MAGEA4 solid tumors. Wikipedia
Founded
Apr 16, 1992
Headquarters
Website
Employees
282
